transcriptomics

Nonhuman primates treated with the mRNA vaccine recovered faster and had less severe disease than those given available mpox vaccines. 

A new method called “REVeRT” expands the capabilities of gene delivery platforms by transporting larger genes than previously possible.  

The durability and capacity to boost protein expression of circular RNA makes it a promising candidate for next-generation vaccines and gene therapies.

Targeting α-synuclein mRNA before it had a chance to aggregate reduced its protein levels in cultured dopaminergic neurons and may protect neurons.

Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.

Researchers discovered that where mRNA translation occurs in the cytoplasm changes protein expression level and sometimes even function.

Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs. 

Pain research has traditionally relied on animal models. Theodore Price studies human tissues to better understand pain disorders across age and sex.

Pioneering approaches transform vaccine technologies and shape the future of disease prevention.

Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.